A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor Patients | MicrobiomeTrials← Back to trialsNCT07404202
A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor Patients
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-03-06Est. Completion: 2026-12-31
Enrollment target: 2,100 participants Locations- Research Site, Beijing, China
- Research Site, Changsha, China
- Research Site, Chengdu, China
- Research Site, Guangzhou, China
- Research Site, Guangzhou, China
- Research Site, Haerbin, China
- Research Site, Jinan, China
- Research Site, Nantong, China
- Research Site, Shanghai, China
- Research Site, Shanghai, China
- Research Site, Shenyang, China
- Research Site, Suzhou, China
- Research Site, Ürümqi, China
- Research Site, Zhejiang, China